Invex Therapeutics Ltd Banner Image

Invex Therapeutics Ltd

  • Ticker IXC
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
Invex Therapeutics Ltd Logo Image
  • 1-10 Employees
  • Based in Subiaco, Australia
Invex Therapeutics is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. Invex has trademarked its repurposed Exenatide as Presendin™.
4.8 / 5.0 (132)

Invex Therapeutics Ltd reports have an aggregate usefulness score of 4.8 based on 132 reviews.

Invex Therapeutics Ltd

Most Recent Annual Report

Invex Therapeutics Ltd
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

Invex Therapeutics Ltd Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!